MENU

Articles for GlaxoSmithKline (LSE: GSK)

Forget cash ISAs! Why bother when you can get 5.5% a year from investing in the GSK share price

Harvey Jones says that FTSE 100 (INDEXFTSE: UKX) pharmaceutical giant GlaxoSmithKline plc (LON: GSK) pays around six times the income you will get from... More »

Is the GlaxoSmithKline share price a bargain or should I buy this high-yielding small-cap?

Does this small-cap share’s recovery potential outshine the forward prospects of GlaxoSmithKline plc (LON: GSK)? More »

GSK and Sopheon’s share prices have beaten the FTSE 100 by 20%, is it time to buy?

Do GlaxoSmithKline plc (LON: GSK) and Sopheon plc (LON: SPE) offer further FTSE 100 (INDEXFTSE: UKX) outperformance potential? More »

Is this FTSE 250 faller set to bounce back and crush the GSK share price?

The GlaxoSmithKline plc (LON: GSK) share price has climbed in 2018, but here's one that could beat it in 2019. More »

FTSE 100 dividend stock GlaxoSmithKline isn’t the only healthcare star that could help you retire rich

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is just one London-quoted healthcare stock that could make you rich. More »

GlaxoSmithKline isn’t the only way to profit from the world’s ageing population

Edward Sheldon looks at a stock which, alongside GlaxoSmithKline plc (LON: GSK), could be set to benefit from the explosion in retirees across the... More »

3 FTSE 100 dividend stocks yielding 5%+ I’d buy for a new SIPP

Roland Head reveals his three top FTSE 100 (INDEXFTSE:UKX) picks for a starter pension portfolio. More »

Is the GSK share price primed to beat the FTSE 100?

Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)? More »

GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now

Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm. More »

Two dirt-cheap FTSE 100 high-yield stocks for bargain hunters

Want to beat the FTSE 100's (INDEXFTSE: UKX) average dividend yield? Consider these near-5%-yielding, bargain-basement shares. More »

A soaring growth candidate plus a FTSE 100 dividend stock I’d buy today

Do you go for growth investing or do you seek dividend income? Here are two stocks that could deliver a combination of both. More »

Build a second income stream with these 2 terrific FTSE 100 dividend stocks

Royston Wild takes a look at two FTSE 100 (INDEXFTSE: UKX) dividend stars that could make you rich. More »

3 top FTSE 100 dividend stocks I’m buying right now

Rupert Hargreaves highlights his three favourite FTSE 100 (INDEXFTSE: UKX) dividend stocks. More »

Here’s why the GSK share price could climb while Spire Healthcare sinks by 20%+

GlaxoSmithKline plc (LON: GSK) appears to offer better investment potential than Spire Healthcare plc (LON: SPI). More »

Here’s why the GSK share price could be set to beat the FTSE 100

GlaxoSmithKline plc (LON: GSK) shares have been lagging the FTSE 100, but could 2018's comeback mark a new upward trend? More »

How did FTSE 100 dividend stock GlaxoSmithKline get to be so risky?

Harvey Jones hopes FTSE 100 (INDEXFTSE: UKX) income stalwart GlaxoSmithKline plc (LSE: GSK) can pull off its tricky balancing act. More »

Is GlaxoSmithKline a high-yield dividend star or a dangerous dog of the FTSE 100?

How sustainable is the GlaxoSmithKline plc (LON: GSK) dividend? More »

GlaxoSmithKline isn’t the only high yield pharma stock I’d buy today

GlaxoSmithKline plc (LON: GSK) isn't the only white-hot dividend stock lurking in the pharmaceuticals space. More »

My 3 favourite FTSE 100 5% yielders

Rupert Hargreaves shares his three favourite FTSE 100 (INDEXFTSE: UKX) income stocks and he thinks they have growth potential. More »

How I’m building a second income with high yielders GSK and Royal Dutch Shell

Edward Sheldon explains how he collects regular dividend cheques from Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK). More »